PRISM MediaWire

Lipella Pharmaceuticals to Progress Development of Oral Graft-versus-Host-Disease Treatment Candidate

New York, March 06, 2024 - PRISM MediaWire - "Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) secures FDA Approval for Investigational New Drug (IND) Application, Advancing Clinical Testing of LP-410 for Oral Graft-Versus-Host Disease (GvHD) Treatment. Clinical Study Set to ...

6 March 2024

SKYX Enters Collaboration with Golden Lighting to Introduce Smart Plug & Play Products into Expanded Sales Channels

New York, March 06, 2024 - PRISM MediaWire - SKYX Platforms Corp. (Nasdaq: SKYX) announces a strategic partnership with Golden Lighting, a renowned manufacturer and premier provider of elegant lighting solutions. This collaboration aims to facilitate SKYX's introduction ...

6 March 2024

IceCure's ProSense® Achieves Complete Tumor Reduction in Early-Stage Breast Cancer

New York, March 06, 2024 - PRISM MediaWire - IceCure Medical Ltd. (Nasdaq: ICCM) has disclosed novel findings from an initial, autonomous breast cancer investigation, revealing a median tumor reduction of 100% at both six and twelve months subsequent to cryoablation in w...

6 March 2024

Sports Gear and Apparel

DRYWORLD Brands (IBGR) Strategically Positions Itself for Game-Changing Impact in 2024 Following Dynamic Moves in 2023

New York, March 05, 2024 - PRISM MediaWire - Today, DRYWORLD Brands, Inc. ($IBGR), a leading global sports brand renowned for premium performance, delivered its annual corporate update to the investment community. The update showcased remarkable achievements, including a...

5 March 2024

Topline Data Anticipated for Suicidal Bipolar Depression Treatment Trial by NRx

New York, March 05, 2024 - PRISM MediaWire - NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) achieves 'Last Patient, Last Visit' milestone in Phase 2b/3 Trial of NRX-101 for suicidal treatment-resistant bipolar depression. The company confirms completion of the 74th and final e...

5 March 2024

Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-410 for Oral Graft-Versus-Host Disease, Advancing Clinical Pipeline

Clinical testing of LP-410 expected to commence in Q2 2024

5 March 2024

Clubhouse Media Group, Inc. Announces HoneyDrip.com Growth Results For February 2024

LOS ANGELES, March 05, 2024 - PRISM MediaWire - Clubhouse Media Group, Inc. (OTC: CMGR) ("CMGR"), a social media firm, today announced that HoneyDrip.com has seen month over month growth, continuing into February 2024. Honeydrip.com is a digital platform designed and wh...

5 March 2024

SensaSure Technologies and Verde Bio Holdings File Registration Statement for Previously Announced Merger

LAS VEGAS, NV, March 05, 2024– PRISM MediaWire - SensaSure Technologies, Inc. (OTCQB: SSTC) (“SensaSure”) and Verde Bio Holdings, Inc. (OTC: VBHI) ("Verde" or the "Company"), a growing oil and gas company with a focus on the acquisition and management of oil and gas mine...

5 March 2024

Quoin Pharmaceuticals Expands Rare Disease Clinical Trials to Encompass Teen Patients

New York, March 04, 2024 - PRISM MediaWire - Clinical-stage biotechnology firm Quoin Pharmaceuticals (Nasdaq: QNRX) has obtained FDA clearance to enroll subjects aged 14 years and above into its two ongoing clinical trials for QRX003. These trials are dedicated to assess...

4 March 2024

Artificial Intelligence:

Advancements in Artificial Intelligence Enhance Travel Experience in 2024: TSA Precheck and Airlines Introduce "Touchless ID" System; BBAI Stock Surges Approximately 30% Following Announcement of "Vision AI" Acquisition

New York, March 04, 2024 - PRISM MediaWire - United Airlines (UA) is set to introduce "Touchless ID" technology, replacing traditional boarding passes and IDs for passengers traveling through Chicago O'Hare and Los Angeles International airports. The program is slated fo...

4 March 2024